1. and . Antiepileptic treatment in pregnant women: morphological and behavioural effects. In: , and , eds. Pediatric clinical pharmacology, handbook of experimental pharmacology 205. Berlin, Heidelberg: Springer Verlag, 2011; 295–315.
2. . 2005 AES annual course: evidence used to treat women with epilepsy. Epilepsia 2006; 47(Suppl 1):46–53.
3. , , , et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes. Neurology 2009; 73:133–41.
4. , , , et al. A summary of the Agency for Healthcare Research and Quality’s evidence report on breastfeeding in developed countries. Breastfeed Med 2009; 4:S17–S30.
5. , , , et al. Breastfeeding and child cognitive development: new evidence from a large randomized trial. Arch Gen Psychiatry 2008; 65:578–84.
6. and . Drug use and breastfeeding. Expert Opin Drug Saf 2005; 4:745–68.
7. and . Drug excretion into breast milk-overview. Adv Drug Deliv Rev 2003; 55:617–27.
8. , , , et al. Anticonvulsants and breast feeding: a critical review. Paediatr Drugs 2000; 2:113–26.
9. and . Antiepileptic drug therapy in pregnancy II: fetal and neonatal exposure. Int Rev Neurobiol 2008; 83:241–58.
10. and . Drug therapy in pregnant and nursing women. In: , , , et al., eds. Principles of clinical pharmacology. Burlington, VT: Academic Press, 2007; 339–57.
11. . Drug therapy for breast-feeding women. New Eng J Med 2000; 343:118–26.
12. and . Neonatal exposure to drugs in breast milk. Pharm Res 2004; 21:555–66.
13. , and . Developmental pharmacokinetics. In: , and , eds. Pediatric clinical pharmacology, handbook of experimental pharmacology 205. Berlin, Heidelberg: Verlag Springer, 2011; 51–75.
14. , , , et al. Developmental pharmacology-drug disposition, action, and therapy in infants and children. New Eng J Med 2003; 349:1157–67.
15. . Children versus adults: pharmacokinetic and adverse-effect differences. Epilepsia 2002; 43:53–9.
17. and . A novel index for expressing exposure of the infant to drugs in breast milk. Br J Clin Pharmacol 1994; 38: 99–102.
18. , , , et al. Countdown to 2015 decade report (2000–10): taking stock of maternal, newborn, and child survival. Lancet 2010; 375:2032–44.
19. and . Incidence and duration of breastfeeding for term infants in Canada, United States, Europe, and Australia: a literature review. Birth 2004; 31:285–92.
20. , , , et al. Continuing drug therapy while breastfeeding. Part 1. Common misconceptions of patients. Can Fam Physician 1999; 45:897–9.
21. , , , et al. Initiation and duration of breast-feeding in women receiving antiepileptics. Am J Obstet Gynecol 1995; 172:881–6.
22. , , , et al. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology 2010; 75:1954–60.
23. , , , et al. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 2006; 117:e1163–e9.
24. and . Anticonvulsant use during lactation. Drug Saf 2000; 22:425–40.
25. and . Perinatal exposure to maternal lamotrigine: clinical considerations for the mother and child. Can Fam Physician 2010; 56:1132–4.